Taking cues from convalescence to improve vaccines against hepatitis C virus
Hepatitis C virus (HCV) infection remains a worldwide public health issue despite direct-acting antivirals. A substantial proportion of infected individuals (15%–45%) spontaneously clear repeated HCV infections with genetically different viruses by generating broadly neutralizing antibodies (bNAbs)....
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2022-08-01
|
Series: | The Journal of Clinical Investigation |
Online Access: | https://doi.org/10.1172/JCI161819 |